Advanced search

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
KLIJN, JGM, LVAM BEEX, L MAURIAC, JA VAN ZIJL, C VEYRET, J WILDIERS, J JASSEM, et al. 2000. “Combined Treatment with Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: A Randomized Study.” Journal of the National Cancer Institute 92 (11): 903–911.
APA
KLIJN, J., BEEX, L., MAURIAC, L., VAN ZIJL, J., VEYRET, C., WILDIERS, J., JASSEM, J., et al. (2000). Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 92(11), 903–911.
Vancouver
1.
KLIJN J, BEEX L, MAURIAC L, VAN ZIJL J, VEYRET C, WILDIERS J, et al. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study. JOURNAL OF THE NATIONAL CANCER INSTITUTE. NATL CANCER INSTITUTE; 2000;92(11):903–11.
MLA
KLIJN, JGM, LVAM BEEX, L MAURIAC, et al. “Combined Treatment with Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: A Randomized Study.” JOURNAL OF THE NATIONAL CANCER INSTITUTE 92.11 (2000): 903–911. Print.
@article{346936,
  author       = {KLIJN, JGM and BEEX, LVAM and MAURIAC, L and VAN ZIJL, JA and VEYRET, C and WILDIERS, J and JASSEM, J and PICCART, M and BURGHOUTS, J and BECQUART, D and SEYNAEVE, C and MIGNOLET, F and Duchateau, Luc},
  issn         = {0027-8874},
  journal      = {JOURNAL OF THE NATIONAL CANCER INSTITUTE},
  language     = {eng},
  number       = {11},
  pages        = {903--911},
  publisher    = {NATL CANCER INSTITUTE},
  title        = {Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study},
  volume       = {92},
  year         = {2000},
}

Web of Science
Times cited: